Lifeward (LFWD) EBIT Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -283.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,016.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,505.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -184.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -3,846.00 |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn | 9,214.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,214.00 |
| Dec 31, 2025 | 12,896.00 |
| Sep 30, 2025 | 56,252.00 |
| Jun 30, 2025 | 16,407.00 |
| Mar 31, 2025 | 39,309.00 |
| Dec 31, 2024 | 10,663.00 |
| Sep 30, 2024 | 8,319.00 |
| Jun 30, 2024 | 15,249.00 |
| Mar 31, 2024 | 10,649.00 |
| Dec 31, 2023 | 13,918.00 |
| Sep 30, 2023 | 23,047.00 |
| Jun 30, 2023 | -23,279.00 |
| Mar 31, 2023 | 11,826.00 |
| Dec 31, 2022 | 4,186.00 |
| Sep 30, 2022 | -36,758.00 |
| Jun 30, 2022 | 20,417.00 |
| Mar 31, 2022 | -26,338.00 |
| Dec 31, 2021 | -95,792.00 |
| Sep 30, 2021 | 11,999.00 |
| Jun 30, 2021 | 7,935.00 |
| Mar 31, 2021 | 14,042.00 |
| Dec 31, 2020 | 14,250.00 |
| Sep 30, 2020 | -10,184.00 |
| Jun 30, 2020 | 11,442.00 |
| Mar 31, 2020 | -24,766.00 |
| Dec 31, 2019 | 23,348.00 |
| Sep 30, 2019 | 28,316.00 |
| Jun 30, 2019 | 56,827.00 |
| Mar 31, 2019 | 8,513.00 |
| Dec 31, 2018 | 121,121.00 |
| Sep 30, 2018 | 28,622.00 |
| Jun 30, 2018 | 65,979.00 |
| Mar 31, 2018 | 49,947.00 |
| Dec 31, 2017 | -1,073.00 |
| Sep 30, 2017 | 19,697.00 |
| Dec 31, 2016 | 20,515.00 |
| Sep 30, 2016 | 2,072.00 |